- Report
- November 2024
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- July 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 192 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- September 2025
- 152 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- December 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- September 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
- Report
- August 2025
- 195 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- March 2025
- 309 Pages
Global
From €3968EUR$4,499USD£3,435GBP
- Report
- May 2025
- 560 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- January 2025
- 165 Pages
Global
From €2513EUR$2,850USD£2,176GBP
- Report
- January 2025
- 165 Pages
Global
From €4101EUR$4,650USD£3,550GBP
- Report
- June 2025
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- November 2024
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- April 2025
- 138 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- February 2025
- 135 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- April 2025
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- February 2025
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more